Targeted next generation sequencing identifies novel NOTCH3 gene mutations in CADASIL diagnostics patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-7364
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeted next generation sequencing identifies novel NOTCH3 gene mutations in CADASIL diagnostics patients ; volume:10 ; number:1 ; day:24 ; month:11 ; year:2016 ; pages:1-12 ; date:12.2016
Human genomics ; 10, Heft 1 (24.11.2016), 1-12, 12.2016
- Creator
-
Maksemous, Neven
- Contributor
-
Smith, Robert A.
Haupt, Larisa M.
Griffiths, Lyn R.
SpringerLink (Online service)
- DOI
-
10.1186/s40246-016-0093-z
- URN
-
urn:nbn:de:1111-2016121520614
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maksemous, Neven
- Smith, Robert A.
- Haupt, Larisa M.
- Griffiths, Lyn R.
- SpringerLink (Online service)
Other Objects (12)
Investigation of AML-specific FLT3 mutations – from next generation diagnostics to combined targeted therapy
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer
Next generation sequencing identifies novel disease-associated BEST1 mutations in Bestrophinopathy patients
Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations
Targeted next-generation sequencing identified novel mutations associated with hereditary anemias in Brazil
Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
Targeted next-generation sequencing identification of mutations in patients with disorders of sex development
Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis
A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations
Targeted 'Next-Generation' sequencing in anophthalmia and microphthalmia patients confirms SOX2, OTX2 and FOXE3 mutations
Identification of gene mutations in patients with primary periodic paralysis using targeted next-generation sequencing
Next generation PIRL for surgery and bio-diagnostics
Investigation of AML-specific FLT3 mutations – from next generation diagnostics to combined targeted therapy
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer
Next generation sequencing identifies novel disease-associated BEST1 mutations in Bestrophinopathy patients
Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations
Targeted next-generation sequencing identified novel mutations associated with hereditary anemias in Brazil
Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
Targeted next-generation sequencing identification of mutations in patients with disorders of sex development
Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis
A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations
Targeted 'Next-Generation' sequencing in anophthalmia and microphthalmia patients confirms SOX2, OTX2 and FOXE3 mutations
Identification of gene mutations in patients with primary periodic paralysis using targeted next-generation sequencing
Next generation PIRL for surgery and bio-diagnostics
Investigation of AML-specific FLT3 mutations – from next generation diagnostics to combined targeted therapy
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer
Next generation sequencing identifies novel disease-associated BEST1 mutations in Bestrophinopathy patients
Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations
Targeted next-generation sequencing identified novel mutations associated with hereditary anemias in Brazil
Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
Targeted next-generation sequencing identification of mutations in patients with disorders of sex development
Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis
A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations
Targeted 'Next-Generation' sequencing in anophthalmia and microphthalmia patients confirms SOX2, OTX2 and FOXE3 mutations
Identification of gene mutations in patients with primary periodic paralysis using targeted next-generation sequencing